COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02196818
Recruitment Status : Recruiting
First Posted : July 22, 2014
Last Update Posted : August 20, 2019
Information provided by (Responsible Party):
Medacta International SA

Brief Summary:
This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.

Condition or disease Intervention/treatment
Osteoarthritis Arthritis Avascular Necrosis Fracture of the Femoral Neck or Head Congenital Hip Dysplasia Device: Mpact Acetabular Shell

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty
Study Start Date : March 2013
Estimated Primary Completion Date : August 2024
Estimated Study Completion Date : August 2024

Group/Cohort Intervention/treatment
Mpact Acetabular Shell
Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.
Device: Mpact Acetabular Shell
Total Hip Replacement

Primary Outcome Measures :
  1. The Kaplan-Meier analysis as a measure of implant performance. [ Time Frame: 5 years ]

Secondary Outcome Measures :
  1. The Harris Hip Score. [ Time Frame: pre-op, 3/6 months, 1,2 and 5 years ]
  2. Radiological analysis as a meausure of safety. [ Time Frame: 3/6 months, 1,2 and 5 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary total hip arthroplasty

Inclusion Criteria:

  • Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
  • Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
  • Patients must be willing to comply with the pre and post-operative evaluation schedule.

Exclusion Criteria:

  • Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02196818

Layout table for location contacts
Contact: Mara Colombo 0041 91 6966060

Layout table for location information
United States, Colorado
Vail Orthopedics, P.C. Recruiting
Denver, Colorado, United States, 80230
Contact: Derek Johnson, MD    303-214-4500   
Principal Investigator: Derek Johnson, MD         
United States, Idaho
Saint Alphonsus Regional Medical Center Recruiting
Boise, Idaho, United States, 83702
Contact: Dennis McGee, MD   
Principal Investigator: Dennis McGee, MD         
United States, Illinois
Illinois Bone & Joint Institute, LLC Recruiting
Libertyville, Illinois, United States, 60048
Contact: Peter Thadani, MD    847-247-4000   
Contact: Keri Malcom    847.247.4000   
Principal Investigator: Peter Thadani, MD         
Sub-Investigator: Keri Malcom         
United States, Utah
Jordan Valley Medical Center Recruiting
West Jordan, Utah, United States, 84088
Contact: Charles Marshall, MD         
Principal Investigator: Charles Marshall, MD         
Sponsors and Collaborators
Medacta International SA
Layout table for additonal information
Responsible Party: Medacta International SA Identifier: NCT02196818    
Other Study ID Numbers: P01.014.08/00
First Posted: July 22, 2014    Key Record Dates
Last Update Posted: August 20, 2019
Last Verified: August 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Hip Dislocation
Hip Dislocation, Congenital
Joint Diseases
Musculoskeletal Diseases
Pathologic Processes
Joint Dislocations
Wounds and Injuries
Hip Injuries
Musculoskeletal Abnormalities
Congenital Abnormalities